Contact Us
Plans and Services Health and Wellness About Wellmark Member Employer Producer Provider
Home Provider Medical Policies and Authorizations Alphabetical Listing


» Working with Wellmark.com
» News
» BlueCard®
» Claims and Payment
» Medical Policies and Authorizations
» Health Management
» Medical, Dental, and Pharmacy
» Credentialing and Contracting
» Quality and Transparency
» Communications and Resources
» Health Care Reform for Providers
printer friendly Printer-Friendly Page

Miscellaneous Surgical Treatments of Back Pain

» Summary» Procedure Codes
» Description» Selected References
» Prior Approval» Policy History
» Policy
 

Medical Policy: 07.01.39 
Original Effective Date: January 2008 
Reviewed: August 2015 
Revised: August 2015 


Benefit Application
Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. Exclusions, limitations or exceptions may apply. Benefits may vary based on contract, and individual member benefits must be verified. Wellmark determines medical necessity only if the benefit exists and no contract exclusions are applicable. This medical policy may not apply to FEP. Benefits are determined by the Federal Employee Program.

This Medical Policy document describes the status of medical technology at the time the document was developed. Since that time, new technology may have emerged or new medical literature may have been published. This Medical Policy will be reviewed regularly and be updated as scientific and medical literature becomes available.


Description: 

A variety of minimally invasive techniques have been investigated over the years as a treatment of low back pain related to disc disease. Techniques can be broadly divided into techniques that are designed to remove or ablate disc material and thus decompress the disc or those that are designed to alter the biomechanics of the disc annulus. The former category includes automated percutaneous lumbar discectomy, laser discectomy, percutaneous laminectomy, and most recently plasma disc decompression using radiofrequency energy, often referred to using the proprietary terms Coblation® or DISC nucleoplasty™.

 

Automated Percutaneous Discectomy

Automated percutaneous lumbar discectomy (APLD) is a minimally invasive surgical technique for treatment of herniated intervertebral discs. For this procedure, a thin, blunt-tipped suction and cutting probe such as the Stryker Dekompressor® Percutaneous Discectomy Probe, or the Endius® MDS MicroDebrider System, is inserted percutaneously and the terminal portion of the probe is placed into the herniated disc using fluoroscopic guidance. The device is used to suction out some or all of the degenerated central disc tissue.

 

Laser Discectomy

A variety of different lasers have been investigated for laser discectomy, including YAG, KTP, holmium, argon, and carbon dioxide lasers. Regardless of the type of laser, the procedure involves placement of the laser within the nucleus under fluoroscopic guidance and then activated. Due to differences in absorption, the energy requirements and the rate of application differ among the lasers. In addition, it is unknown how much disc material must be removed to achieve decompression. Therefore, protocols vary according to the length of treatment, but typically the laser is activated for brief periods only.

 

Coblation

The Disc nucleoplasty™ procedure uses bipolar radiofrequency energy in a process referred to as Coblation technology. The technique consists of small, multiple electrodes that emit a fraction of the energy required by traditional radiofrequency energy systems. The result is that a portion of nucleus tissue is ablated not with heat, but with a low-temperature plasma field of ionized particles. These particles have sufficient energy to break organic molecular bonds within tissue, creating small channels in the disc. The proposed advantage of this Coblation technology is that the procedure provides for a controlled and highly localized ablation, resulting in minimal therapy damage to surrounding tissue.

 

Percutaneous Lysis of Adhesions
Lysis of epidural adhesions, also called the Racz procedure, involves passage of a catheter (Racz catheter) endoscopically or percutaneously, using fluoroscopic guidance, with epidural injections of hypertonic saline in conjunction with corticosteroids and analgesics, has been investigated as a treatment option. Theoretically, the use of hypertonic saline results in a mechanical disruption of the adhesions. It may also function to reduce edema within previously scarred and/or inflamed nerves. Finally, manipulating the catheter at the time of the injection may disrupt adhesions. Spinal endoscopy has been used to guide the lysis procedure, but the procedure is more commonly performed percutaneously using epidurography to guide catheter placement and identify nonfilling adhesions that indicate epidural scarring. Using endoscopy guidance, a flexible fiberoptic catheter is inserted into the sacral hiatus, providing 3-D visualization to steer the catheter toward the adhesions, to more precisely place the injectate in the epidural space and onto the nerve root. Various protocols for lysis have been described; in some situations the catheter may remain in place for several days for serial treatment sessions.

 

Sacroiliac Joint Fusion
Sacroiliac joint fusion, whether performed as an open or minimally invasive (percutaneous) surgical procedure, with or without bone grafts and other metal implant devices, has been proposed as a treatment for individuals who are unresponsive to or cannot tolerate other therapy for chronic low back pain due to sacroiliac joint syndrome and other pain-related sacroiliac conditions.

 

Clinical Guidelines and Recommendations
In April 2013, the American Society of Interventional Pain Physicians published a guideline update titled “An Update of Comprehensive Evidence-based Guidelines for Interventional Techniques in Chronic Spinal Pain. Part II: Guidance and Recommendations” in the journal Pain Physician. In this update, authors assessed the recommendation for a number of variations of percutaneous lumbar discectomy. Recommendations state: The evidence for various modes of percutaneous disc decompression is limited to fair for nucleoplasty, and limited for [automated percutaneous lumbar discectomy] APLD, percutaneous lumbar disc decompression, and decompressor.

 

In 2012, the North American Spine Society released “Clinical Guidelines for Diagnosis and Treatment of Lumbar Disc Herniation with Radiculopathy.”Recommendations state: There is insufficient evidence to make a recommendation for or against the use of tubular discectomy compared with open discectomy to improve the outcomes.


Top


Prior Approval: 

 

Not applicable


Top


Policy: 

Automated percutaneous lumbar discectomy, laser discectomy and intervertebral disc decompression using radiofrequency energy, including but not limited to Coblation® and DISC nucleoplastyTM, are considered investigational as techniques of disc decompression and the treatment of associated pain.

 

There is insufficient evidence to permit conclusions on net health outcomes in the absence of well-designed and executed randomized controlled trials with adequate follow-up.

 

Clinical studies have not established any clinically significant benefit of use of a laser over use of a scalpel for percutaneous lumbar diskectomy.

 

Minimally invasive sacroiliac joint fusion and percutaneous sacroiliac joint fusion procedures are considered investigational.

 

Open Sacroiliac joint fusion procedures are considered medically necessary for any of the following indications:

  1. As an adjunct to sacrectomy or partial sacrectomy related to tumors involving the sacrum; OR
  2. As an adjunct to the medical treatment of sacroiliac joint infection/sepsis; OR
  3. Severe traumatic injuries associated with pelvic ring fracture; OR
  4. During multisegment spinal constructs (for example, correction of deformity in scoliosis or kyphosis surgery) extending to the ilium.

The current evidence on sacroiliac joint fusion is insufficient to permit conclusions regarding the clinical effectiveness of the procedures, whether performed as an open or minimally invasive (percutaneous) surgical procedure, with or without bone grafts and other metal implant devices, for individuals who are unresponsive to or cannot tolerate other therapy for chronic low back pain due to sacroiliac joint syndrome and other pain-related sacroiliac conditions. Prospective trials with standardized selection criteria are needed to identify the role of sacroiliac joint fusion procedures in the management of individuals with these conditions refractory to conservative management.

 

At this time, no evidence-based guidelines regarding sacroiliac spinal fusion procedures are available from the American Association of Neurological Surgeons (AANS), American Academy of Orthopaedic Surgeons (AAOS), American Pain Society (APS), and the North American Spine Society (NASS).

 

There is insufficient evidence in the scientific literature to support the use of sacroiliac joint fusion in treating mechanical low back pain due to sacroiliac joint syndrome and sacral insufficiency fractures. Randomized, controlled trials comparing sacroiliac joint fusion to standard treatments are needed to determine the impact on health outcomes and long-term efficacy.





Top


Procedure Codes and Billing Guidelines: 

  • To report provider services, use appropriate CPT* codes, Modifiers, Alpha Numeric (HCPCS level 2) codes, Revenue codes, and/or diagnosis codes.
  • 27279-Arthrodesis, sacroiliac joint, percutaneous or minimally invasive (indirect visualization), with image guidance, includes obtaining bone graft when performed, and placement of transfixing device
  • 27280-Arthrodesis, open, sacroiliac joint, including obtaining bone graft, including instrumentation, when performed
  • 62263-Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 2 or more days
  • 62264-Percutaneous lysis of epidural adhesions using solution injection (eg, hypertonic saline, enzyme) or mechanical means (eg, catheter) including radiologic localization (includes contrast when administered), multiple adhesiolysis sessions; 1 day
  • 62287 Aspiration or decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, any method, single or multiple levels, lumbar (eg, manual or automated percutaneous discectomy, percutaneous laser discectomy)
  • C2614 Probe, percutaneous lumbar discectomy
  • G0276 Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (PILD) or placebo-control, performed in an approved coverage with evidence development (CED) clinical tria
  • S2348 Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar
  • 0274T - Percutaneous laminotomy/laminectomy (intralaminar approach) for decompression of neural elements, (with or without ligamentous resection, discectomy, facetectomy and/or foraminotomy) any method under indirect image guidance (eg, fluoroscopic, CT), with or without the use of an endoscope, single or multiple levels, unilateral or bilateral; cervical or thoracic

  • 0275T Percutaneous laminotomy/laminectomy (intralaminar approach) for decompression of neural elements, (with or without ligamentous resection, discectomy, facetectomy and/or foraminotomy) any method under indirect image guidance (eg, fluoroscopic, CT), with or without the use of an endoscope, single or multiple levels, unilateral or bilateral; lumbar


Top


Selected References: 

  • The Medical Policy Reference Manual (MPRM) developed by the Blue Cross and Blue Shield Association Health Management Systems, based on Technology Evaluation Center (TEC) criteria.
  • ECRI. Laser Discectomy for the Treatment of Herniated Lumbar Discs. Plymouth Meeting (PA): ECRI Health Technology Information Service; 2009 February 10. 8 p. (ECRI Hotline Response).
  • ECRI. Nucleoplasty (Coblation) for Lumbar Herniated Disc and Discogenic Pain. Plymouth Meeting (PA): ECRI Health Technology Information Service; 2009 January 27. 9 p. (ECRI Hotline Response).
  • Yakovlev A, Tamimi MA, Liang H, Eristavi M. Outcomes of percutaneous disc decompression utilizing nucleoplasty for the treatment of chronic discogenic pain. Pain Physician. 2007 Mar;10(2):319-28.
  • Gibson JNA, Waddell G.  Surgical interventions for lumbar disc prolapse.  Cochrane Database of Systematic Reviews 2007 Apr 18;(2):CD001350.
  • Boswell MV, Trescot AM, et al.  Interventional Techniques: Evidence-based Practice Guidelines in the Management of Chronic Spinal Pain.  Pain Physician 2007; 10:7-111.
  • Singh V, Derby R. Percutaneous lumbar disc decompression. Pain Physician. 2006 Apr;9(2):139-46.
  • Cohen, SP, Williams, S, et al.  Nucleoplasty with or without intradiscal electrothermal therapy (IDET) as a treatment for lumbar herniated disc.  J Spinal Disord Tech 2005;18(SupplS):119-S124.
  • Singh V, Piryani C, Liao K.  Role of percutaneous disc decompression using coblation in managing chronic discogenic low back pain: a prospective, observational study.  Pain Physician. 2004 Oct;7(4):419-25.
  • Ahn Y, Lee SH, Park WM et al. Percutaneous endoscopic lumbar discectomy for recurrent disc herniation: surgical technique, outcome and prognostic factors of 43 consecutive cases. Spine 2004; 29(16):E326-32.
  • Haines SJ, Jordan N, et al. Discectomy strategies for lumbar disc herniation: results of the LAPDOG trial. J Clin Neurosci. 2002 Jul;9(4):411-7.
  • Singh V, Piryani C, et al.  Percutaneous disc decompression using coblation (nucleoplasty) in the treatment of chronic discogenic pain.  Pain Physician. 2002 Jul;5(3):250-9.
  • Revel M, Payan C, Vallee, et al. Automated percutaneous lumbar discectomy versus chemonucleolysis in the treatment of sciatica; A randomized multicenter trial. Spine 1993;18:1-7.
  • Choy DS.  Percutaneous laser disc decompression (PLDD): twelve years' experience with 752 procedures in 518 patients.  J Clin Laser Med Surg. 1998 Dec;16(6):325-31.
  • TARGET [database online]. Plymouth Meeting (PA): ECRI Institute; 2009 Dec 28. Percutaneous disc decompression for cervical disc herniation.
  • Manchikanti L, Boswelll M, Singh V, et.al Comprehensive evidence-based guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician Journal. 2009 July/August;12:699-802.
  • Konstantinovic LM, Kanjuh ZM, Milovanovic AN, et al. Acute low back pain with radiculopathy: a double-blind, randomized, placebo-controlled study. Photomed Laser Surg. 2010 Aug;28(4):553-60.
  • ECRI. Laser Discectomy for the Treatment of Herniated Lumbar Discs. Plymouth Meeting (PA): ECRI Institute; 2011 March 8. (ECRI Hotline Response).
  • ECRI. Nucleoplasty (Coblation) for Lumbar Herniated Disc and Discogenic Pain. Plymouth Meeting (PA):  ECRI Institute; 2011 August 9. (ECRI Hotline Response).
  • ECRI. Dekompressor Lumbar Discectomy for Treating Disc Herniation. Plymouth Meeting (PA):  ECRI Institute; 2012 February 2. [Hotline Response].
  • ECRI. Percutaneous Discectomy for Treating Cervical Disc Herniation. Plymouth Meeting (PA): ECRI Health Technology Information Service; 2012 February 2. [Hotline Response].
  • ECRI. Laser Discectomy for Treating Herniated Lumbar Discs. Plymouth Meeting (PA): ECRI Health Technology Information Service; 2012 September 10. [Hotline Response].
  • Singh V, Manchikanti L, Calodney AK et al. Percutaneous lumbar laser disc decompression: an update of current evidence. Pain Physician 2013; 16(2 Suppl):SE229-60.
  • Manchikanti L, Falco FJ, Benyamin RM et al. An update of the systematic assessment of mechanical lumbar disc decompression with nucleoplasty. Pain Physician 2013; 16(2 Suppl):SE25-54.
  • ECRI. Percutaneous discectomy for treating herniated lumbar disc. ECRI Health Technology Information Service; 2013 December 27. [Hotline Response]. Also available at: http://www.ecri.org.
  • Vleeming A, Albert HB, Ostgaard HC, et al. European guidelines for the diagnosis and treatment of pelvic girdle pain. Eur Spine J. 2008; 17(6):794-819.
  • U.S. Food and Drug Administration (FDA) 510(k) Premarket Notification Database. SImmetry™ Sacroiliac Joint Fusion System Summary of Safety and Effectiveness. No. K110512. Rockville, MD: FDA. March 23, 2011. Available at: http://www.accessdata.fda.gov/cdrh_docs/pdf11/K110512.pdf.
  • North American Spine Society (NASS). Available at: http://www.spine.org/Pages/Default.aspx.
  • Boswell MV, Trescot AM, Datta S et al. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 2007; 10(1):7-111.

Top


Policy History: 

 

Date                                        Reason                               Action

October 2010                         Annual review                     Policy renewed

November 2011                     Annual review                     Policy renewed

November 2012                     Annual review                     Policy renewed

October 2013                        Annual review                     Policy revised

September 2014                    Annual review                     Policy revised

August 2015                         Annual review                     Policy revised


Top


Wellmark medical policies address the complex issue of technology assessment of new and emerging treatments, devices, drugs, etc.   They are developed to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. Wellmark medical policies contain only a partial, general description of plan or program benefits and do not constitute a contract. Wellmark does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Wellmark or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. Our medical policies may be updated and therefore are subject to change without notice.

*Current Procedural Terminology © 2012 American Medical Association. All Rights Reserved.

 
Contact Information
New information or technology that would be relevant for Wellmark to consider when this policy is next reviewed may be submitted to:
  Wellmark Blue Cross and Blue Shield
  Medical Policy Analyst
  P.O. Box 9232
  Des Moines, IA 50306-9232
FacebookTwitterInstagrampinterestLinked InYou Tube